Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 301

The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.

Bone Overgrowth-associated Mutations in the LRP4 Gene Impair Sclerostin Facilitator Function

Open access
Leupin, Olivier, Piters, Elke, Halleux, Christine, Hu, Shouih, Kramer, Ina, Morvan, Frederic, Bouwmeester, Tewis, Schirle, Markus, Bueno-Lozano, Manuel, Ramos Fuentes, Feliciano J., Itin, Peter H., Boudin, Eveline, de Freitas, Fenna, Jennes, Karen, Brannetti, Barbara, Charara, Nadine, Ebersbach, Hilmar, Geisse, Sabine, Lu, Chris X., Bauer, Andreas, Van Hul, Wim, Kneissel, Michaela·2011·Journal of Biological Chemistry

Abstract

Humans lacking sclerostin display progressive bone overgrowth due to increased bone formation. Although it is well established that sclerostin is an osteocyte-secreted bone formation inhibitor, the underlying molecular mechanisms are not fully elucidated. We identified in tandem affinity purification proteomics screens LRP4 (low density lipoprotein-related protein 4) as a sclerostin interaction partner. Biochemical assays with recombinant proteins confirmed that sclerostin LRP4 interaction is direct. Interestingly, in vitro overexpression and RNAi-mediated knockdown experiments revealed that LRP4 specifically facilitates the previously described inhibitory action of sclerostin on Wnt1/β-catenin signaling. We found the extracellular β-propeller structured domain of LRP4 to be required for this sclerostin facilitator activity. Immunohistochemistry demonstrated that LRP4 protein is present in human and rodent osteoblasts and osteocytes, both presumed target cells of sclerostin action. Silencing of LRP4 by lentivirus-mediated shRNA delivery blocked sclerostin inhibitory action on in vitro bone mineralization. Notably, we identified two mutations in LRP4 (R1170W and W1186S) in patients suffering from bone overgrowth. We found that these mutations impair LRP4 interaction with sclerostin and its concomitant sclerostin facilitator effect. Together these data indicate that the interaction of sclerostin with LRP4 is required to mediate the inhibitory function of sclerostin on bone formation, thus identifying a novel role for LRP4 in bone.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m110.190330

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 55 references

Cited by

See all 301

Metadata

Authors
Leupin, O., Piters, E., Halleux, C., Hu, S., Kramer, I., Morvan, F., Bouwmeester, T., Schirle, M., Bueno-Lozano, M., Ramos Fuentes, F. J., Itin, P. H., Boudin, E., de Freitas, F., Jennes, K., Brannetti, B., Charara, N., Ebersbach, H., Geisse, S., Lu, C. X., Bauer, A., Van Hul, W., & Kneissel, M.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2011-06
Volume
286
Issue
22
Pages
19489-19500
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2159406891
Cited by
301
References
55
FWCI
8.70
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Bone Overgrowth-associated Mutations in the LRP4 Gene Impair Sclerostin Facilitator Function. https://app.cochat.ai/papers/10.1074/jbc.m110.190330
The paper
Leupin, O., Piters, E., Halleux, C., Hu, S., Kramer, I., Morvan, F., Bouwmeester, T., Schirle, M., Bueno-Lozano, M., Ramos Fuentes, F. J., Itin, P. H., Boudin, E., de Freitas, F., Jennes, K., Brannetti, B., Charara, N., Ebersbach, H., Geisse, S., Lu, C. X., . . . Kneissel, M. (2011). Bone Overgrowth-associated Mutations in the LRP4 Gene Impair Sclerostin Facilitator Function. Journal of Biological Chemistry. https://doi.org/10.1074/jbc.m110.190330

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.